Insider Shareholders with Direct Ownership of Eloxx Pharmaceuticals, Inc. (ELOX)
This section provides a comprehensive overview of the insiders with direct ownership of Eloxx Pharmaceuticals, Inc. (ELOX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Eloxx Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sumit Aggarwal
PRESIDENT AND CEO |
444,158 | 81,933 | 169,930 $0 | 3 |
Oct 16, 2024
Added 49.26%
|
|
Vijay Modur
HEAD OF R&D |
219,326 | 64,373 | 154,953 $0 | 2 |
Dec 01, 2021
Reduced 29.35%
|
|
Daniel E. Geffken
INTERIM CFO |
50,000 | 0 | 50,000 $0 | 1 |
Nov 29, 2021
Added 50.0%
|
|
Gregory C. Williams
CHIEF EXECUTIVE OFFICER |
53,750 | 16,628 | 44,629 $0 | 6 |
Feb 25, 2021
Reduced 25.6%
|
|
Neil S. Belloff
COO, GENERAL COUNSEL &CORP SEC |
37,500 | 11,092 | 32,699 $0 | 12 |
Jul 30, 2021
Reduced 1.38%
|
|
Alan Edmund Walts
Director |
49,695 | 0 | 12,942 $0 | 2 |
Oct 16, 2024
Added 48.11%
|
|
Lindsay Androski
Director |
12,000 | 0 | 12,000 $0 | 1 |
Oct 16, 2024
Added 50.0%
|
|
Steven D Rubin
Director |
12,000 | 0 | 12,000 $0 | 1 |
Oct 16, 2024
Added 50.0%
|